Announced Sat, 13 Dec · 19:37 IST

Shifting of the Registered Office of the Company within the local limits of the city in the state of Maharashtra and within the jurisdiction of existing Registrar of Companies, with effect ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Relic Technologies' board, which met on December 13, 2025, cleared a wide-ranging set of decisions. The company will allot 4,41,164 equity shares (face value Rs. 10) at Rs. 85 each on conversion of warrants, raising about Rs. 2.81 crore and lifting paid-up capital to Rs. 5.59 crore (55.91 lakh shares). Promoters Nehal Gandhi, Kunal Gandhi and ENAI Trading took ~1.06 lakh shares, while non-promoters Radhika Shriram and Executive Director Karthik Iyer took 3 lakh and 35,000 shares respectively. The board also approved changing the company name to 'Truhealthy Sciences Limited' (CRC already cleared it, pending shareholder approval), introduced an ESOP 2025 scheme covering up to 1,10,000 stock options for employees, appointed Ms. Vibhuti Dani as secretarial auditor for FY26, appointed Mrs. Radhika Shriram as an additional non-executive director, and shifted the registered office within Mumbai effective January 1, 2026. An EGM will be held to seek shareholder approvals.

Likely market impact

The warrant conversion is mildly dilutive (around 9% increase in share count) but brings in fresh capital at a premium. The proposed rebrand to Truhealthy Sciences signals a strategic pivot away from the existing 'Relic Technologies' identity. Shareholders should watch the EGM outcome, as name change, ESOP and further preferential allotments will need their nod.